Bingzhi Wang

779 total citations
59 papers, 530 citations indexed

About

Bingzhi Wang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bingzhi Wang has authored 59 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Bingzhi Wang's work include Gastric Cancer Management and Outcomes (16 papers), Metastasis and carcinoma case studies (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Bingzhi Wang is often cited by papers focused on Gastric Cancer Management and Outcomes (16 papers), Metastasis and carcinoma case studies (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Bingzhi Wang collaborates with scholars based in China, United States and Germany. Bingzhi Wang's co-authors include Liyan Xue, Yanyan Zhao, Zhi Zheng, Shaotong Jiang, Dongdong Mu, Shuizhong Luo, Cheng Li, Kaiqiang Wang, Wen Yang and Yibin Xie and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Bingzhi Wang

54 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingzhi Wang China 14 177 155 130 105 98 59 530
Zhiming Jin China 17 309 1.7× 154 1.0× 422 3.2× 102 1.0× 169 1.7× 24 781
Tae-Su Han South Korea 10 107 0.6× 122 0.8× 212 1.6× 84 0.8× 111 1.1× 16 475
Aki Sakatani Japan 13 177 1.0× 113 0.7× 335 2.6× 113 1.1× 203 2.1× 36 617
Somkiat Sunpaweravong Thailand 13 140 0.8× 207 1.3× 172 1.3× 226 2.2× 44 0.4× 35 525
Zhixuan Li China 11 198 1.1× 77 0.5× 384 3.0× 69 0.7× 303 3.1× 21 729
Minghuan Zheng China 11 70 0.4× 89 0.6× 242 1.9× 118 1.1× 67 0.7× 14 512
Yingfei Li China 12 103 0.6× 32 0.2× 247 1.9× 51 0.5× 65 0.7× 21 408
Miki Yamano Japan 9 190 1.1× 31 0.2× 114 0.9× 159 1.5× 61 0.6× 25 338
Toshihiro Kusaka Japan 10 202 1.1× 215 1.4× 285 2.2× 178 1.7× 143 1.5× 33 633
Hiroki Takaya Japan 9 139 0.8× 19 0.1× 108 0.8× 127 1.2× 36 0.4× 19 421

Countries citing papers authored by Bingzhi Wang

Since Specialization
Citations

This map shows the geographic impact of Bingzhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingzhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingzhi Wang more than expected).

Fields of papers citing papers by Bingzhi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingzhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingzhi Wang. The network helps show where Bingzhi Wang may publish in the future.

Co-authorship network of co-authors of Bingzhi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingzhi Wang. A scholar is included among the top collaborators of Bingzhi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingzhi Wang. Bingzhi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yongjian, Bing Feng, Bingzhi Wang, et al.. (2024). Bi-regional dynamic contrast-enhanced MRI for prediction of microvascular invasion in solitary BCLC stage A hepatocellular carcinoma. Insights into Imaging. 15(1). 149–149.
2.
Huang, Wenting, et al.. (2023). Role of immunophenotypic characterisation in prognostic subtyping of intrahepatic cholangiocarcinoma. Pathology. 55(7). 979–988. 2 indexed citations
3.
Zhang, Jing, Bingzhi Wang, Yu Tang, et al.. (2023). The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I–III triple-negative breast cancer. British Journal of Cancer. 128(11). 2044–2053. 7 indexed citations
4.
Li, Zhuo, et al.. (2023). Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma. Thoracic Cancer. 14(25). 2608–2617. 8 indexed citations
5.
Lin, Hua, et al.. (2023). Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma. BMC Cancer. 23(1). 370–370. 4 indexed citations
6.
Li, Weikun, Fuhai Ma, Bingzhi Wang, et al.. (2023). Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients. Oncology Research and Treatment. 46(7-8). 287–295. 1 indexed citations
7.
Zhu, Yongjian, Peng Wang, Bingzhi Wang, et al.. (2023). Dual-layer spectral-detector CT for predicting microsatellite instability status and prognosis in locally advanced gastric cancer. Insights into Imaging. 14(1). 151–151. 13 indexed citations
8.
Xue, Liyan, Zitong Zhao, Minjie Wang, et al.. (2022). A liquid biopsy signature predicts lymph node metastases in T1 oesophageal squamous cell carcinoma: implications for precision treatment strategy. British Journal of Cancer. 127(11). 2052–2059. 7 indexed citations
9.
Zhao, Yuanyuan, Bing Zhang, Yiming Ma, et al.. (2022). Colorectal Cancer Patient‐Derived 2D and 3D Models Efficiently Recapitulate Inter‐ and Intratumoral Heterogeneity. Advanced Science. 9(22). e2201539–e2201539. 25 indexed citations
10.
Wu, Ming‐Shiang, Shenghui Wang, Yongxing Du, et al.. (2022). Dynamic monitoring revealed a slightly prolonged waiting time for total gastrectomy during the COVID-19 pandemic without increasing the short-term complications. Frontiers in Oncology. 12. 944602–944602. 2 indexed citations
11.
Wu, Ming‐Tsang, Bingzhi Wang, Liyan Xue, et al.. (2022). No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer. World Journal of Gastroenterology. 28(38). 5589–5601. 1 indexed citations
12.
13.
Wang, Bingzhi, Yibin Xie, Zheng Li, et al.. (2021). Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma. BMC Gastroenterology. 21(1). 408–408. 12 indexed citations
14.
Wang, Xiaohui, Zheng Li, Hao Zhao, et al.. (2020). Construction and Analysis of the Tumor-Specific mRNA–miRNA–lncRNA Network in Gastric Cancer. Frontiers in Pharmacology. 11. 1112–1112. 35 indexed citations
15.
Gu, Xiang, Bingzhi Wang, Haiyan Zhu, et al.. (2020). Age-associated genes in human mammary gland drive human breast cancer progression. Breast Cancer Research. 22(1). 64–64. 21 indexed citations
16.
Li, Jie, Benyan Wu, Tao Wu, et al.. (2019). Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia. Diagnostic Pathology. 14(1). 61–61. 1 indexed citations
17.
Chen, Guang, Hakim Bouamar, Bingzhi Wang, et al.. (2019). Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression. Clinical Cancer Research. 26(6). 1486–1496. 19 indexed citations
18.
Hui, Zhouguang, Zitong Zhao, Yueming Zhang, et al.. (2019). PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population. Diagnostic Pathology. 14(1). 6–6. 31 indexed citations
19.
Shao, Kang, Yalong Wang, Qi Xue, et al.. (2019). Clinicopathological features and prognosis of ciliated muconodular papillary tumor. Journal of Cardiothoracic Surgery. 14(1). 143–143. 23 indexed citations
20.
Zhu, Haiyan, Lu Xia, Qi Shen, et al.. (2018). Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Laboratory Investigation. 98(11). 1384–1396. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiming Jin Breakdown of academic impact, for papers by Tae-Su Han Breakdown of academic impact, for papers by Aki Sakatani Breakdown of academic impact, for papers by Somkiat Sunpaweravong Breakdown of academic impact, for papers by Zhixuan Li Breakdown of academic impact, for papers by Minghuan Zheng Breakdown of academic impact, for papers by Yingfei Li Breakdown of academic impact, for papers by Miki Yamano Breakdown of academic impact, for papers by Toshihiro Kusaka Breakdown of academic impact, for papers by Hiroki Takaya
Rankless by CCL
2026